- Home
- VTYX vs FRGE Comparison
VTYX vs FRGE Comparison
Compare VTYX & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- FRGE
- Stock Information
- Founded
- VTYX 2018
- FRGE 2014
- Country
- VTYX United States
- FRGE United States
- Employees
- VTYX N/A
- FRGE N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- FRGE Computer Software: Prepackaged Software
- Sector
- VTYX Health Care
- FRGE Technology
- Exchange
- VTYX Nasdaq
- FRGE Nasdaq
- Market Cap
- VTYX 184.6M
- FRGE 196.1M
- IPO Year
- VTYX 2021
- FRGE N/A
- Fundamental
- Price
- VTYX $2.30
- FRGE $0.94
- Analyst Decision
- VTYX Buy
- FRGE Strong Buy
- Analyst Count
- VTYX 5
- FRGE 3
- Target Price
- VTYX $8.40
- FRGE $4.50
- AVG Volume (30 Days)
- VTYX 2.3M
- FRGE 710.3K
- Earning Date
- VTYX 11-07-2024
- FRGE 11-06-2024
- Dividend Yield
- VTYX N/A
- FRGE N/A
- EPS Growth
- VTYX N/A
- FRGE N/A
- EPS
- VTYX N/A
- FRGE N/A
- Revenue
- VTYX N/A
- FRGE $79,799,000.00
- Revenue This Year
- VTYX N/A
- FRGE $19.18
- Revenue Next Year
- VTYX N/A
- FRGE $34.32
- P/E Ratio
- VTYX N/A
- FRGE N/A
- Revenue Growth
- VTYX N/A
- FRGE 18.08
- 52 Week Low
- VTYX $1.67
- FRGE $0.80
- 52 Week High
- VTYX $11.48
- FRGE $4.02
- Technical
- Relative Strength Index (RSI)
- VTYX 47.68
- FRGE 39.86
- Support Level
- VTYX $2.21
- FRGE $0.90
- Resistance Level
- VTYX $2.54
- FRGE $1.25
- Average True Range (ATR)
- VTYX 0.27
- FRGE 0.09
- MACD
- VTYX -0.05
- FRGE -0.01
- Stochastic Oscillator
- VTYX 8.02
- FRGE 2.14
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The Company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.